CION Ameerpet
There is no good word for what you are. Not a patient, not entirely well — holding information about a future that may never arrive. The word previvor exists because nothing else fitted, and it was coined by people in exactly your position.
Medicine is organised around people who are ill and people who are not. A positive predictive genetic test puts you somewhere in between, and the system has no obvious place for you. You are not a cancer patient — you have no cancer. You are also not simply well, because you are now attending appointments, weighing operations, and being asked to make decisions that healthy people never face.
The word previvor was coined by carriers themselves, not by clinicians, precisely because no existing term described the experience. It is a slightly awkward word. It is also genuinely useful, because naming a state makes it discussable, and a great deal of what is difficult about this is that it does not fit anywhere.
This page is about that part. The clinical pathway — surveillance, the timing of risk-reducing surgery, cascade testing — is set out elsewhere on this site and is reasonably well defined. What is not well covered anywhere is what it is actually like, and what other people in the same position have found helps.
The system is built around ill and not-ill. A predictive result puts you somewhere it has no name for.
"Previvor" was coined by people in this position, not by clinicians, because nothing else fitted.
Surveillance and surgery timing are defined. What it feels like to live inside those decisions is not.
The distress associated with carrying a hereditary cancer variant is well recognised and is considered part of what hereditary cancer services should address — not a side issue and not a sign that someone is coping badly. Studies of carriers consistently describe health anxiety, heightened attention to ordinary bodily sensations, difficulty with the open-ended nature of the risk, and significant distress around informing relatives. Good genetic counselling includes this explicitly, and asking for psychological support is a reasonable request rather than an admission of anything. Source: published literature on the psychosocial impact of predictive genetic testing.
Gathered from what carriers consistently describe. If you recognise yourself in these, that is the point.
Bloating that would once have been a heavy meal becomes a reason to check the calendar. A twinge in the pelvis holds your attention for a week. This heightened vigilance is close to universal among carriers, and it is exhausting in a way that is difficult to convey to people who do not have it.
What helps most is having a clear rule agreed in advance — for example, symptoms new within the past year, present on more than twelve days a month, lasting more than two to three weeks, get reported. A defined threshold converts a constant low-level monitoring into an occasional decision, which is a considerably lighter load. See the symptom checklist.
Risk-reducing surgery works. It also brings menopause forward by years, and it ends the possibility of pregnancy with your own eggs. If you are in your mid-thirties, those two facts sit directly against each other and no amount of thinking resolves them into a right answer.
What genuinely helps is reframing it from a puzzle with a solution to a trade-off you are entitled to weigh according to your own values. Two women with identical results and identical family histories can reasonably reach opposite decisions. Neither is wrong. See risk-reducing surgery.
Scan anxiety is a recognised phenomenon and it is often worse than the appointment itself. Carriers describe several bad days beforehand and a period of relief afterwards that shortens each cycle — until it barely arrives at all before the next one is due.
Practical measures help more than they sound like they should: booking the earliest appointment of the day so there is less waiting time, arranging to get results quickly rather than by post, taking someone with you, and planning something for immediately afterwards. Tell your team if the anxiety is significant, because scheduling can often be adapted.
Most carriers find this the single hardest part. Some relatives want to know immediately. Some are angry — usually displaced fear rather than anything about you. Some never respond at all, which is its own kind of difficult. And a parent who passed the variant on frequently carries guilt that is entirely unwarranted and very hard to talk them out of.
The framing that helps most is narrow: your responsibility is making the information available in a form people can act on. It is not making them act, and it is not managing their feelings about it. Ask your genetics service for a family letter written to be passed on. See cascade testing.
Carriers very commonly describe feeling that they have no right to find this hard, because they do not have cancer and other people do. That comparison is understandable and it is not a useful one. Uncertainty about the future is a genuinely difficult thing to carry, and it does not become easier because someone else is carrying something different.
It also tends to stop people asking for support they would readily accept in another context. Distress in carriers is well documented and is considered part of what hereditary cancer services address. Asking for help with it is a reasonable request, not a concession.
Most difficult medical situations have a shape — a treatment, a course, an end. This does not. The risk is present at 30 and at 50, decisions get revisited rather than settled, and there is no point at which the file closes and you go back to how things were.
Carriers who describe managing it well often talk about deliberately containing it: fixed appointments in the calendar, a defined symptom threshold, and permission to not think about it in between. That is a skill rather than a personality trait, and it is one that support can genuinely help with.
Consistently reported by people in this position. Not a prescription — take what applies.
A written plan you can look at: which surveillance, when, who arranges it, and a specific symptom threshold for when to make contact. Vagueness is what turns a manageable risk into constant background monitoring. Having a defined rule converts an ongoing state of vigilance into an occasional decision, which is a very different weight to carry day to day.
Carriers consistently describe peer contact as the thing that helped most — not because advice is exchanged, but because the in-between state stops needing explanation. Support organisations for hereditary cancer exist internationally and increasingly in India, and your genetics service can usually point you towards one. Even one other person who gets it changes the experience considerably.
None of these means you are coping badly. Each is a reasonable prompt to mention it to your team.
Persistent intrusive thinking about cancer risk, rather than around appointments and decisions, is worth naming to someone.
Skipping or postponing surveillance because of dread is common and is exactly when support is most useful.
Persistent sleep disturbance, low mood or loss of interest are treatable in their own right and should not be endured.
Being genuinely unable to move on the surgery question over a long period is a reason to seek help with it, not a character flaw.
Disclosure damaging relationships is common and painful. Genetics services deal with this regularly and can help.
Repeated self-examination or frequent symptom searching beyond an agreed threshold is a recognised pattern and is manageable.
Distress in carriers is documented and expected, not a sign of weakness. Support is part of hereditary cancer care rather than an add-on you have to justify.
The timing conversation is age-defined but it is not an emergency. Coming in to think out loud, without deciding anything, is a perfectly good reason for an appointment.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Genetic counselling at CION covers the living-with-it side, not just the biology.
Most hereditary cancer appointments are dominated by numbers — lifetime risks, surgical timing windows, surveillance intervals. All of that matters, and it also tends to crowd out the questions people actually leave with, which are usually some version of how am I supposed to live with this.
Your first consultation at CION is free and runs to about 45 minutes. Genetic counselling is delivered in-house, and it is meant to cover this side of it as well as the biology. Coming in specifically to think out loud, without deciding anything, is a perfectly reasonable use of an appointment — and if you would prefer to see a woman doctor, say so when you book.
We will also say plainly what we cannot do. There is no correct answer to the timing question, and anyone who gives you one is overreaching. What we can do is make sure you have the actual figures for your gene and family history, a clear surveillance plan, a defined symptom threshold, and somewhere to bring it when it gets heavy. Risk-reducing surgery is coordinated with specialist partner centres and may be billed there.
Free and unhurried. Long enough to get past the numbers to the questions you actually came with.
Coming in to think out loud, without reaching a decision, is a legitimate reason for an appointment.
Say so when you book. CION is a woman-headed organisation and this is a normal request.
Surveillance schedule, symptom threshold, and who to contact — written down rather than remembered.
Partners and close family frequently want to help and are unsure how, particularly because there is no illness to respond to and no obvious task to take on. A few things are reported as consistently useful.
Do not solve it. The strong instinct is to resolve the decision — to point out that surgery obviously reduces risk, or that she is worrying about something that may never happen. Both may be factually true and neither helps, because the difficulty is not a lack of information. Sitting with an unresolved thing alongside someone is more useful than trying to close it for them.
Remember the dates. Surveillance appointments and the days before them are hard, and being asked about it unprompted lands very differently from having to raise it. And if you are the parent who passed the variant on, the guilt is common and entirely unwarranted — you did not choose your genes, and the information you have made available is what allows something to be done about it.
The difficulty is not missing information. Sitting alongside an unresolved thing helps more than closing it.
Asking unprompted about a scan lands very differently from having to bring it up.
Nobody chooses their genes, and passing on the information is what makes anything possible.
Arranging appointments, chasing results, going along. Concrete help is easier to accept than reassurance.
It describes someone who carries a known hereditary cancer predisposition — most often a BRCA1 or BRCA2 variant — but has not developed cancer. The term was coined by carriers themselves rather than by clinicians, because no existing word described the experience: you are not a patient, since you have no cancer, but you are not simply well either, given that you attend appointments and face decisions healthy people never encounter. It is a slightly awkward word that is genuinely useful, because naming a state makes it discussable, and much of what is hard about this is that it fits nowhere.
Yes, and it is well documented rather than a sign that you are coping badly. Studies of carriers consistently describe health anxiety, heightened attention to ordinary bodily sensations, difficulty with the open-ended nature of the risk, and significant distress around informing relatives. Carriers also very commonly report feeling they have no right to struggle, because other people have actual cancer — an understandable comparison that is not a useful one. Uncertainty about the future is genuinely difficult to carry, and it does not become easier because someone else carries something different.
Complete freedom from it is probably not a realistic goal, but converting constant background monitoring into an occasional decision is. What helps most is agreeing a specific threshold with your team in advance — for example, symptoms new within the past year, present on more than twelve days a month, and lasting more than two to three weeks get reported. A defined rule means you are not re-evaluating every sensation on its own merits. Alongside that, having a clear route to being seen quickly if something does cross the threshold removes much of what makes vigilance feel necessary.
By accepting that it is a trade-off rather than a puzzle with a hidden solution. Surgery reduces ovarian cancer risk by around eighty per cent; it also brings menopause forward by years and ends the possibility of pregnancy with your own eggs. Those facts sit directly against each other and no amount of thinking resolves them into a correct answer. Two women with identical results and family histories can reasonably decide differently, and neither is wrong. What helps is having your actual figures for your gene and family history, understanding how surgical menopause would be managed, and giving yourself permission to weigh it by your own values.
Almost never today, and rarely this month. The recommended windows for risk-reducing surgery are age-defined — generally from around 35 to 40 for BRCA1 carriers and 40 to 45 for BRCA2 — but they are windows rather than deadlines, and the decision is revisited rather than made once. Deferring while you complete a family or simply while you think is a legitimate choice, provided you understand that ovarian surveillance is not effective protection in the meantime. Coming to an appointment specifically to think out loud, without deciding anything, is a perfectly good reason to be there.
By keeping your responsibility narrow. Your job is making the information available in a form people can act on — ideally with a family letter from a genetics service, so you are not explaining the science yourself. It is not making them test, and it is not managing their feelings about it. Anger is common and is usually displaced fear rather than anything about you. Silence is common too and is its own kind of hard. A parent who passed the variant on frequently carries entirely unwarranted guilt. Genetics services deal with all of this regularly and can help.
Yes. The first consultation is free and runs to about 45 minutes, and genetic counselling at CION is delivered in-house and is meant to cover the living-with-it side as well as the biology. Coming in to think out loud without deciding anything is a legitimate reason for an appointment, and you can ask to see a woman doctor when you book. What you should leave with is your actual risk figures, a written surveillance plan, a defined symptom threshold and a route to being seen. Risk-reducing surgery is coordinated with specialist partner centres and may be billed there.